ET
CRL icon

Entropy Technologies’s Charles River Laboratories CRL Stock Holding History

Entropy Technologies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,881
Closed -$974K – 941
2025
Q4 		$974K Sell
4,881
-9,025
-65% -$1.64M 0.05% 391
2025
Q3 		$2.18M Buy
13,906
+12,487
+880% +$1.98M 0.16% 174
2025
Q2 		$215K Buy
+1,419
New +$189K 0.02% 688
2025
Q1 		– Sell
-4,310
Closed -$796K – 765
2024
Q4 		$796K Sell
4,310
-815
-16% -$157K 0.08% 324
2024
Q3 		$1.01M Sell
5,125
-5,408
-51% -$1.12M 0.11% 259
2024
Q2 		$2.18M Buy
10,533
+7,143
+211% +$1.62M 0.24% 129
2024
Q1 		$919K Sell
3,390
-2,518
-43% -$601K 0.1% 305
2023
Q4 		$1.4M Buy
+5,908
New +$1.16M 0.26% 123

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Entropy Technologies's CRL Position: Q1 2026 in Review

Entropy Technologies sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 4,881 shares — an estimated $974K sold.

Entropy Technologies first reported a position in CRL in Q4 2023 and held it in 8 quarters. The position peaked at $2.18M in Q2 2024. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Entropy Technologies reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Entropy Technologies sold 4,881 Charles River Laboratories shares in Q1 2026, an estimated $974K.
  • Entropy Technologies first reported a position in Charles River Laboratories in Q4 2023 and held it in 8 quarters.
  • Entropy Technologies's Charles River Laboratories position peaked at $2.18M in Q2 2024.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.